Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Navarixin in allergen-induced asthma
NCT00688467Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Jun 2008
- Primary completion
- Mar 2009
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of navarixin in asthma, sponsored by Merck & Co.. Started Jun 2008; status: completed.
02
Drugs
navarixin
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00688467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00688467.